NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-006659 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
68,147
Total Value
$88,012.75
P&L
+inf% (+$1,548,290.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Ordinary Shares | โ | Jan 5, 2026 | Sale | 2,647 | $33.25 | $88,012.75 | 12,353 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jan 7, 2026 | Grant/Award | 12,000 | โ | โ | 24,353 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Jan 7, 2026 | Grant/Award | 53,500 | $0.00 | $0.00 | 53,500 | Direct | โ | View Details |